Advances in basic and translational tuberculosis research : Proceedings of the first meeting of RePORT international - 18/04/17

Doi : 10.1016/j.tube.2016.11.006

Carolina Geadas ^a, Sonia K. Stoszek ^b, David Sherman ^c, Bruno B. Andrade ^d, Sudha Srinivasan ^e, Carol D. Hamilton ^f, Jerrold Ellner ^a,^⁎
^a Boston Medical Center and Boston University School of Medicine, Department of Medicine, Section of Infectious Diseases, Boston, MA, USA
^b Health Studies Sector, Westat, Rockville, MD, USA
^c Center for Infectious Disease Research, Seattle, WA, USA
^d Unidade de Medicina Investigativa, Laboratório Integrado de Microbiologia e Imunorregulação, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil
^e Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
^f Scientific Affairs, Global Health, Population and Nutrition, FHI 360, Department of Medicine, Division of Infectious Diseases, Duke University School of Medicine, Durham, NC, USA

^∗Corresponding author. Boston Medical Center and Boston University School of Medicine, Section of Infectious Disease, 801 Massachusetts Avenue, 2nd Floor, Room 2013, Boston, MA, USA.Boston Medical Center and Boston University School of MedicineSection of Infectious Disease801 Massachusetts Avenue2nd Floor, Room 2013BostonMAUSA

Abstract

RePORT International is a collaborative research network of investigators from multiple countries and institutions with the goal of establishing a bio-repository of specimens and clinical data for the study of active TB and latent TB infection (LTBI). During the first meeting of RePORT International in Boston, Massachusetts, the results of research pertinent to TB control and eradication were presented, including advances in the research of Mycobacterium tuberculosis (MTB) persistence and drug resistance, TB diagnostics, drug and vaccine development.

Le texte complet de cet article est disponible en PDF.

Keywords : RePORT, Tuberculosis, Research, Advances

Plan

The mission of RePORT

Introduction

Drug resistance and MTB persistence

Export

Vol 102

P. 55-67 - janvier 2017 Retour au numéro

Article précédent

The role of CD30 and CD153 (CD30L) in the anti-mycobacterial immune response
Nancy D. Marín, Luis F. García

| Article suivant

Mycobacterium tuberculosis Rv0560c is not essential for growth in vitro or in macrophages
Rachel Kokoczka, Dorothée L. Schuessler, Julie V. Early, Tanya Parish

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

connectez-vous ou créez un compte

Advances in basic and translational tuberculosis research : Proceedings of the first meeting of RePORT international - 18/04/17

Abstract

Plan

Export citations

Fichier

Contenu

Accès rapides

Mon compte

Aide & support

Plateformes Elsevier Masson

Déclaration CNIL